Cargando…

Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model

OBJECTIVE. To investigate the anti-tumor effect of a newly-developed dual inhibitor (APCS-540) of glycogen synthase kinase 3 beta (GSK3B) and histone deacetylases (HDACs) in ovarian cancer cells. METHODS. The effects of APCS-540 on cancer cell proliferation, migration, invasion and cancer stemness w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylan, Enes, Zayou, Fouzia, Murali, Ramachandran, Karlan, Beth Y., Pandol, Stephen J., Edderkaoui, Mouad, Orsulic, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769125/ https://www.ncbi.nlm.nih.gov/pubmed/32698955 http://dx.doi.org/10.1016/j.ygyno.2020.07.005

Ejemplares similares

What are the macrophages and stellate cells doing in pancreatic adenocarcinoma?
por: Pandol, Stephen J., et al.
Publicado: (2015)

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
por: Pimienta, Michael, et al.
Publicado: (2017)

Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
por: Elmadbouh, Omer H. M., et al.
Publicado: (2022)

Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?
por: Hu, Ye, et al.
Publicado: (2020)

HDAC3 mediates smoking-induced pancreatic cancer
por: Edderkaoui, Mouad, et al.
Publicado: (2016)

Ciliated Cells in Ovarian Cancer Decrease with Increasing Tumor Grade and Disease Progression
por: Richardson, Michael T., et al.
Publicado: (2022)

Determination of Rottlerin, a Natural Protein Kinases C Inhibitor, in Pancreatic Cancer Cells and Mouse Xenografts by RP-HPLC Method
por: Lu, Qing-Yi, et al.
Publicado: (2012)

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
por: Recouvreux, Maria Sol, et al.
Publicado: (2022)

Smoking and Pancreatic Disease
por: Edderkaoui, Mouad, et al.
Publicado: (2013)

Risk factors for pancreatic cancer: underlying mechanisms and potential targets
por: Edderkaoui, Mouad, et al.
Publicado: (2014)

Dynamic Changes in the Extracellular Matrix in Primary, Metastatic, and Recurrent Ovarian Cancers
por: Gertych, Arkadiusz, et al.
Publicado: (2022)

Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer
por: Beach, Jessica A., et al.
Publicado: (2015)

Sequestration of Intestinal Acidic Toxins by Cationic Resin Attenuates Pancreatic Cancer Progression through Promoting Autophagic Flux for YAP Degradation
por: Zhao, Guangfu, et al.
Publicado: (2022)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder
por: Loi, Manuela, et al.
Publicado: (2021)

MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC)
por: Li, Ce, et al.
Publicado: (2019)

Robotics in reproduction, fertility preservation, and ovarian transplantation
por: Taylan, Enes, et al.
Publicado: (2017)

Aspirin use correlates with survival in women with clear cell ovarian cancer
por: Wield, Alyssa M., et al.
Publicado: (2018)

Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment
por: Taylor-Harding, B, et al.
Publicado: (2012)

HDAC6 and Ovarian Cancer
por: Haakenson, Joshua, et al.
Publicado: (2013)

Computational pathology in ovarian cancer
por: Orsulic, Sandra, et al.
Publicado: (2022)

FOXC2 augments tumor propagation and metastasis in osteosarcoma
por: Gozo, Maricel C., et al.
Publicado: (2016)

Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT
por: Kanska, Justyna, et al.
Publicado: (2017)

A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas
por: Haro, Marcela, et al.
Publicado: (2018)

Inflammation is a key contributor to ovarian cancer cell seeding
por: Jia, Dongyu, et al.
Publicado: (2018)

Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma
por: Wu, Jingni, et al.
Publicado: (2022)

A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models
por: Mrdenovic, Stefan, et al.
Publicado: (2023)

Attributions of survival and methods of coping of long-term ovarian cancer survivors: a qualitative study
por: Ketcher, Dana, et al.
Publicado: (2021)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

Electroacupuncture improves TBI dysfunction by targeting HDAC overexpression and BDNF-associated Akt/GSK-3β signaling
por: Hung, Shih-Ya, et al.
Publicado: (2022)

Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
por: Wiedemeyer, W. Ruprecht, et al.
Publicado: (2014)

Hdac1 and Hdac2 regulate the quiescent state and survival of hair-follicle mesenchymal niche
por: Sibony-Benyamini, Hadas, et al.
Publicado: (2023)

Natural chalcones as dual inhibitors of HDACs and NF-κB
por: ORLIKOVA, B., et al.
Publicado: (2012)

Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer
por: Roy, Rubi, et al.
Publicado: (2023)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome
por: Engler, David A., et al.
Publicado: (2012)

Whole ovary immunohistochemistry for monitoring cell proliferation and ovulatory wound repair in the mouse
por: Singavarapu, Rajasekhar, et al.
Publicado: (2010)

Antagonistic role of GSK3 isoforms in glioma survival
por: Vashishtha, Vidhi, et al.
Publicado: (2018)

Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release
por: Daniel, Kevin B., et al.
Publicado: (2015)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_snm61h2pin4h70unaoqn0ltuci